Clinical Trial Update: A Pilot Study of Liver Protection Using Prednisone for Patients Receiving Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a pilot study of prednisone for liver protection in patients with hepatocellular carcinoma receiving stereotactic body …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PREDNISONE (Prednisone)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: RECRUITING